Machine Learning Times
EXCLUSIVE HIGHLIGHTS
AI Business Value Is Not an Oxymoron: How Predictive AI Delivers Real ROI for Enterprises
  Originally published in AI Realized Now “Shouldn’t a great...
How To Un-Botch Predictive AI: Business Metrics
  Originally published in Forbes Predictive AI offers tremendous potential...
2 More Ways To Hybridize Predictive AI And Generative AI
  Originally published in Forbes Predictive AI and generative AI...
How To Overcome Predictive AI’s Everyday Failure
  Originally published in Forbes Executives know the importance of predictive...
SHARE THIS:

11 years ago
Video: Predictive Analytics: Advancing Precision and Population Medicine

 

This speaker session is from Predictive Analytics World for Healthcare, October, 5–9, 2014 in Boston, MA:

This content is restricted to site members. If you are an existing user, please log in on the right (desktop) or below (mobile). If not, register today and gain free access to original content and industry news. See the details here.

Comments are closed.

 George Savage is the Chief Medical Officer and co-founder of Proteus Digital Health, and formerly the company’s vice president of research and development. Dr. Savage has started ten companies since 1989 as entrepreneur or founding investor, including FemRx (acquired by Johnson and Johnson), CardioRhythm (acquired by Medtronic) and QRx Pharmaceuticals (ASX IPO). Dr. Savage holds a B.S. in biomedical engineering from Boston University, where he graduated magna cum laude and Tau Beta Pi, an M.D. from Tufts University School of Medicine and an M.B.A. from Stanford University Graduate School of Business. Dr. Savage serves on the boards of

This content is restricted to site members. If you are an existing user, please log in on the right (desktop) or below (mobile). If not, register today and gain free access to original content and industry news. See the details here.